BRIEF published on 10/22/2024 at 07:05, 30 days 6 hours ago Implenia Secures Major Hotel Construction Contract in the Swiss Alps Sustainability Construction Switzerland Implenia Andermatt
PRESS RELEASE published on 10/22/2024 at 07:00, 30 days 6 hours ago Implenia wins contract to build large new hotel in Switzerland Implenia wins contract to build large new hotel in Switzerland. Implenia appointed as total contractor by Andermatt Swiss Alps AG for hotel & residences in Andermatt, part of Andermatt Reuss development Construction Switzerland Implenia Hotel Andermatt
BRIEF published on 09/23/2024 at 07:10, 1 month 28 days ago Implenia supports merger discussions between Ina Invest and Cham Group Shareholders Merger Real Estate Implenia Discussions
PRESS RELEASE published on 09/23/2024 at 07:05, 1 month 28 days ago Implenia welcomes talks about possible merger of Ina Invest and Cham Group Implenia welcomes talks on potential merger between Ina Invest and Cham Group. Letter of intent signed. Talks at early stage. Shareholders to vote Spring 2025 if positive outcome Merger Implenia Ina Invest Cham Group Swiss Property
BRIEF published on 09/06/2024 at 07:05, 2 months 15 days ago Implenia receives excellent marks for its ESG initiatives ESG MSCI Implenia Sustainalytics Rating
PRESS RELEASE published on 09/06/2024 at 07:00, 2 months 15 days ago Implenia once again earns top scores in the sustainability ratings of MSCI and Sustainalytics Implenia earns top sustainability ratings from MSCI and Sustainalytics, reinforcing its industry leadership in ESG. AAA rating confirmed by MSCI, 88 points in Sustainalytics’ ESG rating ESG MSCI Implenia Sustainalytics Sustainability Ratings
BRIEF published on 08/21/2024 at 06:50, 3 months ago Changes on the Implenia Executive Committee Executive Committee Leadership Changes Implenia André Wyss Jens Vollmar
PRESS RELEASE published on 08/21/2024 at 06:45, 3 months ago Changes on the Implenia Executive Committee Implenia AG announces changes on the Executive Committee with CEO André Wyss stepping down in March 2025 and Jens Vollmar appointed as the new CEO from April 1, 2025. Christian Späth to step down in August 2024 Executive Committee Implenia AG André Wyss Jens Vollmar Christian Späth
PRESS RELEASE published on 08/21/2024 at 06:45, 3 months ago Implenia achieved good EBIT again in the first half-year and confirms targets for 2024 Implenia achieved good EBIT of CHF 50.5 million in the first half-year 2024, confirming targets for 2024. Divisions showed positive results, with increased revenue and high order book Revenue EBIT Implenia Targets Divisions
BRIEF published on 07/12/2024 at 07:05, 4 months 9 days ago Implenia wins major railway project in Gothenburg, Sweden Infrastructure Implenia Mobility West Link Gothenburg
Published on 11/21/2024 at 13:00, 32 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 32 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 32 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 32 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 32 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 57 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 17 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 34 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 12 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 47 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 47 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
